These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3437853)

  • 21. Proliferating cell nuclear antigen expression by erythroid precursors in normal bone marrow, in reactive lesions and in polycythaemia rubra vera.
    Thiele J; Meuter RB; Titius RB; Zankovich R; Fischer R
    Histopathology; 1993 May; 22(5):429-35. PubMed ID: 8102113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of coexisting primary hypogonadism and polycythemia rubra vera.
    Reddy GN; Nagar S; Trubowitz S
    J Med Soc N J; 1980 Jun; 77(6):430-2. PubMed ID: 6930496
    [No Abstract]   [Full Text] [Related]  

  • 23. Statins in the treatment of polycythaemia vera and allied disorders: an antithrombotic and cytoreductive potential?
    Hasselbalch HC; Riley CH
    Leuk Res; 2006 Oct; 30(10):1217-25. PubMed ID: 16483650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polycythemia vera: clinical and histopathological studies on its prognosis and the progressive course toward leukemia].
    Hoshino T; Nakayama S; Itani S; Okada H; Sumida M; Takashima A; Takahashi T; Horiuchi T; Okada T; Uchida A; Yagita M; Sugiyama H
    Nihon Ketsueki Gakkai Zasshi; 1983 May; 46(3):685-99. PubMed ID: 6613499
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.
    Thiele J; Kvasnicka HM
    Ann Hematol; 2003 Mar; 82(3):148-52. PubMed ID: 12634946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Colony-forming capacity of stromal elements of the bone marrow of polycythemia vera patients].
    Filev LV; Kazhdan IIa; Kotsiubinskiĭ NN; Zaritskiĭ AIu
    Ter Arkh; 1980; 52(9):76-8. PubMed ID: 7434238
    [No Abstract]   [Full Text] [Related]  

  • 27. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
    Panteli K; Zagorianakou N; Bai M; Katsaraki A; Agnantis NJ; Bourantas K
    Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic myeloproliferative diseases on a pathologist's desk--a dilemma of distinct entities versus a clinico-pathologic continuum. A descriptive study based on a material from the Polish population.
    Rudzki Z; Papla B; Stachura J
    Pol J Pathol; 2004; 55(1):13-23. PubMed ID: 15195702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lytic bone lesions in polycythaemia rubra vera.
    Jacoks P; Wood L; Goodman H
    Eur J Haematol; 1990 Nov; 45(5):275-7. PubMed ID: 2261957
    [No Abstract]   [Full Text] [Related]  

  • 30. Histologic criteria for classification and differential diagnosis of chronic myeloproliferative disorders.
    Frisch B; Bartl R; Burkhardt R; Jäger K
    Haematologia (Budap); 1984; 17(2):209-26. PubMed ID: 6534829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.
    Thiele J; Funke S; Holgado S; Choritz H; Georgii A
    Anal Quant Cytol; 1984 Sep; 6(3):155-67. PubMed ID: 6594964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera.
    Kvasnicka HM; Thiele J
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):362-71. PubMed ID: 16810612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary polycythaemia. 3. Studies on the significance of the history of the disease and of the treatment for the development of clones in bone marrow cells.
    Visfeldt J; Franzén S; Nielsen A; Tribukait B
    Acta Pathol Microbiol Scand A; 1973 Mar; 81(2):195-203. PubMed ID: 4734062
    [No Abstract]   [Full Text] [Related]  

  • 34. The polycythaemia rubra vera-1 gene is constitutively expressed by bone marrow cells and does not discriminate polycythaemia vera from reactive and other chronic myeloproliferative disorders.
    Bock O; Serinsöz E; Neusch M; Schlué J; Kreipe H
    Br J Haematol; 2003 Nov; 123(3):472-4. PubMed ID: 14617008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypocholesterolemia in myeloproliferative disorders.
    Spanos GA; Bajaj K; Rosner F
    Arch Intern Med; 1981 Jan; 141(1):137-8. PubMed ID: 6934710
    [No Abstract]   [Full Text] [Related]  

  • 36. Bone marrow histopathology in myeloproliferative disorders--current diagnostic approach.
    Thiele J; Kvasnicka HM; Orazi A
    Semin Hematol; 2005 Oct; 42(4):184-95. PubMed ID: 16210032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders.
    Ferrero D; Tarella C; Pregno P; Pileri A; Gallo E
    Cancer Res; 1986 Feb; 46(2):975-80. PubMed ID: 3455679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron metabolism in polycythaemia rubra vera and secondary polycythaemia.
    Nagy G; Dezsö I; Varsányi M
    Haematologia (Budap); 1975; 9(1-2):79-84. PubMed ID: 1230402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulomonocytic progenitor cells (CFC*) cultured from patients with polycythaemia vera.
    Parmentier C; Morardet N; Gardet P; Droz JP; Charbord P; Caillou B
    Nouv Rev Fr Hematol (1978); 1980; 22(4):339-55. PubMed ID: 7255155
    [No Abstract]   [Full Text] [Related]  

  • 40. Erythroid colony formation in vitro in bone marrow cells of polycythemia vera.
    Kimura H; Terasawa T; Maruyama W; Tanaka T; Matsuda S; Akitsuki T; Yoshida H; Uchida T; Kasai S; Kariyone S
    Nihon Ketsueki Gakkai Zasshi; 1978 Aug; 41(4):679-87. PubMed ID: 716783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.